Literature DB >> 21763484

Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability.

Muhammad Arshad Rafiq1, Andreas W Kuss, Lucia Puettmann, Abdul Noor, Annapoorani Ramiah, Ghazanfar Ali, Hao Hu, Nadir Ali Kerio, Yong Xiang, Masoud Garshasbi, Muzammil Ahmad Khan, Gisele E Ishak, Rosanna Weksberg, Reinhard Ullmann, Andreas Tzschach, Kimia Kahrizi, Khalid Mahmood, Farooq Naeem, Muhammad Ayub, Kelley W Moremen, John B Vincent, Hans Hilger Ropers, Muhammad Ansar, Hossein Najmabadi.   

Abstract

We have used genome-wide genotyping to identify an overlapping homozygosity-by-descent locus on chromosome 9q34.3 (MRT15) in four consanguineous families affected by nonsyndromic autosomal-recessive intellectual disability (NS-ARID) and one in which the patients show additional clinical features. Four of the families are from Pakistan, and one is from Iran. Using a combination of next-generation sequencing and Sanger sequencing, we have identified mutations in the gene MAN1B1, encoding a mannosyl oligosaccharide, alpha 1,2-mannosidase. In one Pakistani family, MR43, a homozygous nonsense mutation (RefSeq number NM_016219.3: c.1418G>A [p.Trp473*]), segregated with intellectual disability and additional dysmorphic features. We also identified the missense mutation c. 1189G>A (p.Glu397Lys; RefSeq number NM_016219.3), which segregates with NS-ARID in three families who come from the same village and probably have shared inheritance. In the Iranian family, the missense mutation c.1000C>T (p.Arg334Cys; RefSeq number NM_016219.3) also segregates with NS-ARID. Both missense mutations are at amino acid residues that are conserved across the animal kingdom, and they either reduce k(cat) by ∼1300-fold or disrupt stable protein expression in mammalian cells. MAN1B1 is one of the few NS-ARID genes with an elevated mutation frequency in patients with NS-ARID from different populations.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763484      PMCID: PMC3135808          DOI: 10.1016/j.ajhg.2011.06.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations.

Authors:  Rebecca Bedilu; Katherine A Nummy; Alan Cooper; Ron Wevers; Jan Smeitink; Wim J Kleijer; Karen H Friderici
Journal:  Mol Genet Metab       Date:  2002-12       Impact factor: 4.797

Review 2.  The epidemiology of mental retardation: challenges and opportunities in the new millennium.

Authors:  Helen Leonard; Xingyan Wen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

3.  Mapping of three novel loci for non-syndromic autosomal recessive mental retardation (NS-ARMR) in consanguineous families from Pakistan.

Authors:  M A Rafiq; M Ansar; C R Marshall; A Noor; N Shaheen; A Mowjoodi; M A Khan; G Ali; M Amin-ud-Din; L Feuk; J B Vincent; S W Scherer
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

4.  Mechanism of class 1 (glycosylhydrolase family 47) {alpha}-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control.

Authors:  Khanita Karaveg; Aloysius Siriwardena; Wolfram Tempel; Zhi-Jie Liu; John Glushka; Bi-Cheng Wang; Kelley W Moremen
Journal:  J Biol Chem       Date:  2005-02-15       Impact factor: 5.157

Review 5.  The prevalence of mental retardation: a critical review of recent literature.

Authors:  N Roeleveld; G A Zielhuis; F Gabreëls
Journal:  Dev Med Child Neurol       Date:  1997-02       Impact factor: 5.449

Review 6.  X-linked mental retardation.

Authors:  H-Hilger Ropers; Ben C J Hamel
Journal:  Nat Rev Genet       Date:  2005-01       Impact factor: 53.242

7.  Autosomal recessive mental retardation: homozygosity mapping identifies 27 single linkage intervals, at least 14 novel loci and several mutation hotspots.

Authors:  Andreas Walter Kuss; Masoud Garshasbi; Kimia Kahrizi; Andreas Tzschach; Farkhondeh Behjati; Hossein Darvish; Lia Abbasi-Moheb; Lucia Puettmann; Agnes Zecha; Robert Weissmann; Hao Hu; Marzieh Mohseni; Seyedeh Sedigheh Abedini; Anna Rajab; Christoph Hertzberg; Dagmar Wieczorek; Reinhard Ullmann; Saghar Ghasemi-Firouzabadi; Susan Banihashemi; Sanaz Arzhangi; Valeh Hadavi; Gholamreza Bahrami-Monajemi; Mahboubeh Kasiri; Masoumeh Falah; Pooneh Nikuei; Atefeh Dehghan; Masoumeh Sobhani; Payman Jamali; Hans Hilger Ropers; Hossein Najmabadi
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

8.  [Alpha-mannosidosis].

Authors:  D Malm; O K Tollersrud; L Tranebjaerg; J E Månsson
Journal:  Tidsskr Nor Laegeforen       Date:  1995-02-20

9.  Prevalence of lysosomal storage disorders.

Authors:  P J Meikle; J J Hopwood; A E Clague; W F Carey
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

10.  The genetic basis of non-syndromic intellectual disability: a review.

Authors:  Liana Kaufman; Muhammad Ayub; John B Vincent
Journal:  J Neurodev Disord       Date:  2010-07-29       Impact factor: 4.025

View more
  29 in total

1.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders.

Authors:  Hossein Najmabadi; Hao Hu; Masoud Garshasbi; Tomasz Zemojtel; Seyedeh Sedigheh Abedini; Wei Chen; Masoumeh Hosseini; Farkhondeh Behjati; Stefan Haas; Payman Jamali; Agnes Zecha; Marzieh Mohseni; Lucia Püttmann; Leyla Nouri Vahid; Corinna Jensen; Lia Abbasi Moheb; Melanie Bienek; Farzaneh Larti; Ines Mueller; Robert Weissmann; Hossein Darvish; Klaus Wrogemann; Valeh Hadavi; Bettina Lipkowitz; Sahar Esmaeeli-Nieh; Dagmar Wieczorek; Roxana Kariminejad; Saghar Ghasemi Firouzabadi; Monika Cohen; Zohreh Fattahi; Imma Rost; Faezeh Mojahedi; Christoph Hertzberg; Atefeh Dehghan; Anna Rajab; Mohammad Javad Soltani Banavandi; Julia Hoffer; Masoumeh Falah; Luciana Musante; Vera Kalscheuer; Reinhard Ullmann; Andreas Walter Kuss; Andreas Tzschach; Kimia Kahrizi; H Hilger Ropers
Journal:  Nature       Date:  2011-09-21       Impact factor: 49.962

Review 2.  Clinical utility gene card for: MAN1B1 defective congenital disorder of glycosylation.

Authors:  Jaak Jaeken; Dirk J Lefeber; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2015-11-18       Impact factor: 4.246

3.  MAN1B1 Mutation Leads to a Recognizable Phenotype: A Case Report and Future Prospects.

Authors:  Sabine Hoffjan; Jörg T Epplen; André Reis; Rami Abou Jamra
Journal:  Mol Syndromol       Date:  2015-03-04

4.  The class I α1,2-mannosidases of Caenorhabditis elegans.

Authors:  Iain B H Wilson
Journal:  Glycoconj J       Date:  2012-04-26       Impact factor: 2.916

5.  Bone Dysplasia as a Key Feature in Three Patients with a Novel Congenital Disorder of Glycosylation (CDG) Type II Due to a Deep Intronic Splice Mutation in TMEM165.

Authors:  R Zeevaert; F de Zegher; L Sturiale; D Garozzo; M Smet; M Moens; G Matthijs; J Jaeken
Journal:  JIMD Rep       Date:  2012-08-22

6.  Inhibition of endoplasmic reticulum associated degradation reduces endoplasmic reticulum stress and alters lysosomal morphology and distribution.

Authors:  Hyung Lim Elfrink; Rob Zwart; Frank Baas; Wiep Scheper
Journal:  Mol Cells       Date:  2013-03-18       Impact factor: 5.034

7.  A Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control.

Authors:  Michael J Iannotti; Lauren Figard; Anna M Sokac; Richard N Sifers
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

Review 8.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin.

Authors:  Ashlee H Sun; John R Collette; Richard N Sifers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

10.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.